NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
2.290
-0.040 (-1.70%)
At close: Feb 21, 2025, 4:00 PM
2.310
+0.020 (0.87%)
After-hours: Feb 21, 2025, 4:00 PM EST
NeurAxis Revenue
NeurAxis had revenue of $666.63K in the quarter ending September 30, 2024, with 39.62% growth. This brings the company's revenue in the last twelve months to $2.46M, down -3.36% year-over-year. In the year 2023, NeurAxis had annual revenue of $2.46M, down -8.37%.
Revenue (ttm)
$2.46M
Revenue Growth
-3.36%
P/S Ratio
6.06
Revenue / Employee
$129,275
Employees
19
Market Cap
16.58M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.46M | -224.69K | -8.37% |
Dec 31, 2022 | 2.68M | -36.55K | -1.34% |
Dec 31, 2021 | 2.72M | 791.06K | 40.98% |
Dec 31, 2020 | 1.93M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNRXS News
- 4 weeks ago - UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States - GlobeNewsWire
- 4 weeks ago - NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States - GlobeNewsWire
- 5 weeks ago - NeurAxis Inc. Issues Letter to Shareholders - GlobeNewsWire
- 6 weeks ago - NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - GlobeNewsWire
- 3 months ago - NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues - GlobeNewsWire
- 4 months ago - NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewsWire
- 5 months ago - NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewsWire